tert-Butyl 4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl]piperidine-1-carboxylate

We are tert-Butyl 4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl]piperidine-1-carboxylate CAS:877399-74-1 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:tert-Butyl 4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl]piperidine-1-carboxylate
CAS.NO:877399-74-1
Synonyms:4-[4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-pyrazol-1-yl]piperidine-1-carboxylic acid tert-butyl ester
Molecular Formula:C19H32BN3O4
Molecular Weight:377.28600
 
Physical and Chemical Properties:
Density:1.14
Boiling point:492.803ºC
Flash point:251.838ºC
Index of Refraction:1.539
 
Specification:
Appearance:Off-white powder
Purity:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Crizotinib
 
Note:The product under valid patents will not be offered to the countries covered by patents.

tert-Butyl 4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl]piperidine-1-carboxylate


Related News: Active Pharmaceutical Ingredients (APIs): Pharmaceutical active ingredients, which are the basic substances that constitute the pharmacological effects of pharmaceuticals, and are prepared by chemical synthesis, plant extraction, or biotechnology.1,3-dichloro-2-methoxybenzene Active Pharmaceutical Ingredients (APIs): Pharmaceutical active ingredients, which are the basic substances that constitute the pharmacological effects of pharmaceuticals, and are prepared by chemical synthesis, plant extraction, or biotechnology.2,5-Dimethylfuran At the same time, because the profits of a single variety of characteristic APIs do not have long-term growth, companies need more product reserves.Ácido 10- (2-naftil) antraceno-9-borónico CAS:597554-03-5 At the same time, because the profits of a single variety of characteristic APIs do not have long-term growth, companies need more product reserves.China will use its national drug bulk-buy scheme to lower the price of drugs currently sold at higher prices compared with other markets, it said in an official statement.

Related Products
Product Name
3-Chloropropyltrichlorosilane View Details
Bromocyclopentane View Details
4-Amino-3-chlorophenol hydrochloride View Details
3-Bromopropionyl chloride manufacturer (S)-N-(4-(2,5-Dioxooxazolidin-4-yl)butyl)-2,2,2-trifluoroacetamide manufacturer 4,5-Difluoro-2-methoxybenzonitrile manufacturer Diethoxyphosphorylmethyl 4-methylbenzenesulfonate manufacturer DL-Tyrosine manufacturer